Therapeutics for Women's Health: Technologies and Global Markets

Report Code: BIO043E

Publish Date: May 2014

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for women’s health therapeutics was worth nearly $18.3 billion in 2012. The market is expected to increase from nearly $19 billion in 2013 to nearly $22.5 billion by 2018, a compound annual growth rate (CAGR) of 3.5% for the five-year period, 2013 to 2018.

Report Includes

  • An overview of the global therapeutics for women's health market.
  • Analyses of global market trends, with data from 2012 and 2013, and projections of CAGRs through 2018.
  • Information on women's health disorder types including infertility, endometriosis, postmenopausal osteoporosis, menopause, and polycystic ovary syndrome (PCOS).
  • Detailed analysis of annual costs as well discussion on branded vs. generics.
  • Specifics on market factors such as drivers, restraints, competition, and market shares.
  • Information on marketed as well as pipeline drugs and therapies.

Report Scope

This report is an analytical business tool whose primary purpose is to describe the thorough evaluation of the global market for women's health therapeutics. The format of the study is organized around the following topics:

  • Detailed study around women's diseases such as endometriosis, postmenopausal osteoporosis, menopause and polycystic ovary syndrome (PCOS).
  • Disease incidence and prevalence.
  • Regulatory structure.
  • Market characterization, unmet need, market size and segmentation.
  • Market drivers and restraints.
  • Detailed market projections through 2018.
  • Competition and market shares.
  • Pricing and reimbursement.
  • Marketed and pipeline (R&D) products along with description, regulatory status and clinical trials.
  • Observations and conclusions regarding the future of women's health therapeutics market.
  • Profiles of market participants and associations.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Analyst Credentials

Dr. Ritu Thakur is an independent consultant based in New Delhi, India with 10+ years of experience in consulting, business/market research, business & report writing, analytics, content development & management and translation. She has prior work experience with Panasonic (Healthcare Division), GlobalData (U.K.-based market research firm) and several other development stage/early stage companies including Biovo, Diabesity, Medibrane, ScaleThings, EndoGI, Ramot Biomedical Eng and NeverWet. In her previous assignments, she has delivered hundreds of small to large scale custom projects on pharmaceutical, medical and biotechnology subjects. She has developed reports for BCC Research for more than four years and has worked as an author for healthcare and other related industries such as pharmaceuticals, biotechnology and medical devices.

Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Therapeutics for Women's Health: Technologies and Global Markets184Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: SUMMARY2Free
Chapter- 3: OVERVIEW OF WOMEN'S HEALTH DISORDERS9Free
Chapter- 4: MENOPAUSE-RELATED SYMPTOMS AND DISEASES11Free
Chapter- 5: POSTMENOPAUSAL OSTEOPOROSIS19Free
Chapter- 6: ENDOMETRIOSIS17Free
Chapter- 7: POLYCYSTIC OVARY SYNDROME11Free
Chapter- 8: WOMEN'S HEALTH DISORDER THERAPEUTICS MARKET ASSESSMENT16Free
Chapter- 9: COMPETITION AND MARKET SHARES2Free
Chapter- 10: MARKET STRATEGY7Free
Chapter- 11: DRUG PIPELINE ANALYSIS28Free
Chapter- 12: REGULATORY STRUCTURE5Free
Chapter- 13: PRICING AND REIMBURSEMENT4Free
Chapter- 14: CONCLUSIONS-OUTLOOK FOR WOMEN'S HEALTH THERAPEUTICS9Free
Chapter- 15: APPENDIX A: COMPANY PROFILES23Free
Chapter- 16: APPENDIX B: INDUSTRY AND PROFESSIONAL ORGANIZATIONS6Free
Chapter- 17: APPENDIX C: ACTIVE CLINICAL TRIALS8Free
Chapter- 18: APPENDIX D: ABBREVIATIONS3Free
Published - Mar-2009| Analyst - Melissa Elder| Code - BIO043D

Report Highlights

  • The U.S. market for therapeutics and diagnostics for women’s disorders was worth $29.9 billion in 2008. This should increase to $50.0 billion in 2013, for a compound annual growth rate (CAGR) of 10.9%.
  • The rheumatoid arthritis and osteoporosis segment has the largest share of the market, generating $10.6 billion in 2008. This is expected to grow at a CAGR of 11.5% to reach $18.2 billion in 2013.
  • Reproductive related therapies and diagnostics currently have the second largest market share, worth $5.9 billion in 2008. This should reach $7.5 billion in 2013, for a CAGR of 5.0%.
Published - May-2005| Analyst - Melissa Elder| Code - BIO043C

Report Highlights

  • The total U.S. market for new therapeutics and diagnostics for women’s disorders was estimated at more than $25 billion in 2004 and is expected to reach nearly $41 billion in 2009, rising at an AAGR (average annual growth rate) of 10.3%.
  • Treatments for cancers specific to women will rise the fastest, at an AAGR of 12.6% and will lead revenues in 2009.
  • Reproductive-related therapies and diagnostics currently represent the largest market segment, but, rising at an AGR of 8.4%, will lag slightly by 2009.
  • Treatments for gynecological diseases and infections and for rheumatoid arthritis and osteoporosis also represent large market segments.
Published - Jan-2001| Analyst - Mary Anne Crandall| Code - BIO043B

Report Highlights

  • The total current U.S. market for new therapeutics and diagnostics for women's disorders in 1999 reached $16.9 billion at the manufacturers' level. The growing numbers of women combined with the growing trend to take an active role in healthcare has driven growth in this market. By 2005, it is anticipated that revenues will likely reach $31.9 billion, growing at an average annual rate of 8.7%.
  • The reproductive-related therapeutics and diagnostics holds the largest market revenues position representing 31.9% and accounting for $5.4 billion of the total in 1999. Large numbers of women in the baby boomer age group, coupled with large numbers of the mini-boomers (daughters of the baby boomer generation), contributed to the reproductive-related therapeutics and diagnostics' dominate role in 1999. It is anticipated that the reproductive-related therapeutics and diagnostics will remain the largest market share throughout the forecast period as it crosses $10 billion by 2005.

Related Reports

Human Reproductive Technologies: Products and Global Markets

Published - Nov 2013 | Publisher - Mary Anne Crandall | Code - HLC017D

The total market for reproductive technologies and products is estimated to achieve revenues of nearly $16.1 billion in 2013. In 2018, the forecasted revenues will likely reach $19.6 billion, demonstrating a compound annual growth rate (CAGR) of 4.1%.

Therapies and Diagnostics for Uterine Cancer

Published - Sep 2013 | Publisher - Usha Nagavarapu | Code - HLC142A

The global market for uterine cancer treatments and diagnostics reached $17.4 billion in 2012. This market is expected to grow to nearly $17.8 billion in 2013 and then to nearly $21.6 billion in 2018, a compound annual growth rate (CAGR) of 3.9% over the five-year period from 2013 to 2018.

Therapies and Diagnostics for Cervical Cancer

Published - Aug 2013 | Publisher - Usha Nagavarapu | Code - HLC141A

The global cervical cancer market for drugs and diagnostics was $11.3 billion in 2012 and is expected to grow from $11.6 billion in 2013 to $15.6 billion by 2018, a compound annual growth rate (CAGR) of 6.1%.

Therapies and Diagnostics for Ovarian Cancer

Published - Jun 2013 | Publisher - Usha Nagavarapu | Code - HLC143A

The global ovarian cancer drug and diagnostic market was valued at $16.1 billion in 2012. The market is predicted to grow to $18.7 billion in 2013 and $34.6 billion by 2018, a compound annual growth rate (CAGR) of 13.1% between 2013 and 2018.

Recent Reports

Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics

Published - Jun 2024 | Publisher - Gundreddy Gopinadh | Code - BIO157C

The global market for polymerase chain reaction for point-of-care diagnostics is expected to grow from $1.6 billion in 2024 to $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Flow Cytometry: Products, Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO085F

The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

PEGylated Proteins Market

Published - May 2024 | Publisher - BCC Publishing | Code - BIO253A

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.

Companion Diagnostics: Technologies and Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO077F

The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Therapeutics for Women's Health: Technologies and Global Markets
Customize Report